Myalgic encephalomyelitis (ME), also known as chronic fatigue syndrome, affects over 500,000 people in France, with cases rising significantly since the Covid-19 pandemic. Alain Moreau is one of the world’s top scientists on the question. The director of the interdisciplinary Canadian collaborative myalgic encephalomyelitis research discusses advancements in research, including the genetic signature of ME, current research priorities, and the gap between scientific understanding and public perception.
Keywords for this article
